BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3679306)

  • 1. Usefulness of serum lipid and LCAT levels in diagnosing chronic hepatic dysfunction in liver cirrhosis.
    Chadha MD; Abraham P; Nerurkar S; Taskar SP; Naik SR
    Indian J Gastroenterol; 1987 Oct; 6(4):201-3. PubMed ID: 3679306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK; Dolgov AV; Kurilovich SA
    Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid substrates for LCAT activity in liver disease.
    Salvioli G; Lugli R; Salati R
    Scand J Gastroenterol; 1977; 12(7):841-7. PubMed ID: 202014
    [No Abstract]   [Full Text] [Related]  

  • 4. LCAT activity as a prognostic liver function test.
    Horton RC; Owen JS
    Lancet; 1990 Jul; 336(8709):249-50. PubMed ID: 1973798
    [No Abstract]   [Full Text] [Related]  

  • 5. [The behavior of lecithin cholesterol acyltransferase (LCAT) in acute viral hepatitis and post-hepatitis cirrhosis].
    Falsetti F; Proto C; Fernicola C; Ielasi G
    Minerva Med; 1979 Jan; 70(5):399-404. PubMed ID: 440618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients.
    Parsons HG; Thirsk JE; Frohlich J; Dias V; Minuk GY
    Clin Invest Med; 1989 Dec; 12(6):386-91. PubMed ID: 2612091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma lecithin-cholesterol acyltransferase activity (LCAT) in late schistosomiasis and chronic liver disease].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1985 Jan; 24(1):31-3, 63. PubMed ID: 3979186
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipids in liver disease.
    Shahid A
    J Pak Med Assoc; 1992 Nov; 42(11):258-9. PubMed ID: 1479635
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoaffinity-isolation of plasma lecithin-cholesterol acyltransferase (LCAT) from patients with hepatic cirrhosis.
    Chawla D; Malik AM; Lima VL; Owen JS
    Biochem Soc Trans; 1998 May; 26(2):S147. PubMed ID: 9649822
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma lipoproteins and LCAT in chronic liver disease.
    Rao PN; Radha V
    Indian J Gastroenterol; 1987 Oct; 6(4):197-8. PubMed ID: 3679305
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum apoproteins A and B and the lecithin: cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients.
    Nayak SS; Ramani A; Kamath SS; Kundaje GN; Aroor AR
    Biochem Med Metab Biol; 1988 Dec; 40(3):299-304. PubMed ID: 3233186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin: cholesterol acyltransferase activity in patients with chronic liver diseases and positive LP-X tests.
    Jung K; Schimmelpfennig W; Wack R; Neumann R
    Digestion; 1978; 17(5):445-8. PubMed ID: 210070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered lipid composition and differential changes in activities of membrane-bound enzymes of erythrocytes in hepatic cirrhosis.
    Kakimoto H; Imai Y; Kawata S; Inada M; Ito T; Matsuzawa Y
    Metabolism; 1995 Jul; 44(7):825-32. PubMed ID: 7616839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of lecithin cholesterol acyltransferase (LCAT) in non-cirrhotic alcoholics].
    Falsetti F; Proto C; Balestrieri GP; Quadri A
    Minerva Dietol Gastroenterol; 1978; 24(3):191-6. PubMed ID: 740275
    [No Abstract]   [Full Text] [Related]  

  • 15. LCAT activity as a prognostic liver function test.
    Clements D; Banerjee S; Smith PM
    Lancet; 1990 Sep; 336(8717):752. PubMed ID: 1975924
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of lecithin-cholesterol acyltransferase (LCAT) in the detection of early forms of atherosclerosis].
    Choluj B; Zichová M; Vodák M; Klestincová J; Votruba T; Sedlák F
    Vnitr Lek; 1986 Nov; 32(11):1073-8. PubMed ID: 3798774
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased plasma lecithin:cholesterol acyltransfer and associated changes in plasma and red cell lipids in uraemia.
    Gillett MP; Teixeira V; Dimenstein R
    Nephrol Dial Transplant; 1993; 8(5):407-11. PubMed ID: 8393544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of parenchymal liver disease.
    Day RC; Harry DS; Owen JS; Foo AY; McIntyre N
    Clin Sci (Lond); 1979 Jan; 56(6):575-83. PubMed ID: 225095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease.
    Tahara D; Nakanishi T; Akazawa S; Yamaguchi Y; Yamamoto H; Akashi M; Chikuba N; Okuno S; Maeda Y; Kusumoto Y
    Metabolism; 1993 Jan; 42(1):19-23. PubMed ID: 8446043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin:cholesterol acyltransferase activity, plasma and lipoprotein lipids and obesity in men and women.
    Sutherland WH; Temple WA; Nye ER; Herbison PG
    Atherosclerosis; 1979 Nov; 34(3):319-27. PubMed ID: 518742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.